Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06187584 · ClinicalTrials.gov registry record · Phase 4

SCHF Post-Op Study Between Opioid and Non-Opioid Pain Management

A Phase 4 study of Supracondylar Humerus Fracture, sponsored by Children's Mercy Hospital Kansas City.

Active
Registry status
Phase 4
Development phase
160
Enrollment target
1
Study location

NCT06187584 is a Phase 4 study of Supracondylar Humerus Fracture that is active but no longer recruiting, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 160 participants, above the 135-participant average among 3 other Supracondylar Humerus Fracture trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06187584, a Phase 4 study of Supracondylar Humerus Fracture, is active but no longer recruiting, sponsored by Children's Mercy Hospital Kansas City.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

This purpose of this study is to determine the efficacy of nonopioid versus opioid analgesic regimens following surgical fixation of Gartland Type III Supracondylar Humoral Fractures (SCHFs) to assist in the development of a standard outpatient pain management regimen in the treatment of these injuries.

Interventions

  • DRUG Acetaminophen
  • DRUG Ibuprofen
  • DRUG Hydrocodone/acetaminophen

Study Locations (1)

Missouri

  • Children's Mercy Hospital & Clinics - Kansas City

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2019-04-15
Est. Completion 2026-12-31
Phase Phase 4

What the Registry Record Tells You About NCT06187584

The ClinicalTrials.gov registry entry for NCT06187584 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 135-participant average among 3 other Supracondylar Humerus Fracture trials with a reported enrollment target (19% higher). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Supracondylar Humerus Fracture appearing as the primary indexed condition, and to 3 interventions - of which Acetaminophen is the first listed.

NCT06187584 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT06187584 about?

NCT06187584 is a clinical study titled "SCHF Post-Op Study Between Opioid and Non-Opioid Pain Management". This purpose of this study is to determine the efficacy of nonopioid versus opioid analgesic regimens following surgical fixation of Gartland Type III Supracondylar Humoral Fractures (SCHFs) to assist in the development of a standard outpatient pain management regimen in the treatment of these injur...

What is the current status of trial NCT06187584?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 160 participants. The study started on 2019-04-15. Estimated completion is 2026-12-31.

What conditions does trial NCT06187584 study?

This clinical trial studies the following conditions: Supracondylar Humerus Fracture.

What interventions are being tested in trial NCT06187584?

The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), Hydrocodone/acetaminophen (DRUG).

Who is sponsoring clinical trial NCT06187584?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06187584 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Supracondylar Humerus Fracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.